Preclinical toxicology of alpha-2'-deoxythioguanosine (NSC-71851).
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001792:Blood Platelets / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003853:Deoxyribonucleosides / Q000008:administration & dosage / Q000633:toxicity*; D003967:Diarrhea / Q000139:chemically induced; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004906:Erythrocyte Count; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D000882:Haplorhini; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008214:Lymphocytes / Q000187:drug effects; D008251:Macaca; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000032:analysis* / Q000633:toxicity; D009504:Neutrophils / Q000187:drug effects; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D003853:Deoxyribonucleosides; D015122:Mercaptopurine